Risultati per: Terapia della BPCO, fra Linee Guida GOLD e normativa
Questo è quello che abbiamo trovato per te
Terapia derivata dalle cellule staminali contro il cancro al fegato resistente al trattamento
Il 65% dei pazienti utilizzerebbe una terapia digitale
PoliMi, l’IA rivoluzionerà medicina personalizzata entro 5 anni
Linea guida sull’incontinenza dopo il trattamento della prostata
Prima terapia farmacologica per l’apnea notturna (OSAS)
Linee guida sull’uso di farmaci antiepilettici in gravidanza
Linee guida sulle cure palliative nei pazienti affetti da cancro
Linee guida su adenocarcinoma dell’intestino tenue
Linea guida sulla cardiomiopatia ipertrofica
Risk equations for prosthetic joint infections (PJIs) in UK: a retrospective study using the Clinical Practice Research Datalink (CPRD) AURUM and GOLD databases
Background
Prosthetic joint infections (PJIs) are a serious negative outcome of arthroplasty with incidence of about 1%. Risk of PJI could depend on local treatment policies and guidelines; no UK-specific risk scoring is currently available.
Objective
To determine a risk quantification model for the development of PJI using electronic health records.
Design
Records in Clinical Practice Research Datalink (CPRD) GOLD and AURUM of patients undergoing hip or knee arthroplasty between January 2007 and December 2014, with linkage to Hospital Episode Statistics and Office of National Statistics, were obtained. Cohorts’ characteristics and risk equations through parametric models were developed and compared between the two databases. Pooled cohort risk equations were determined for the UK population and simplified through stepwise selection.
Results
After applying the inclusion/exclusion criteria, 174 905 joints (1021 developed PJI) were identified in CPRD AURUM and 48 419 joints (228 developed PJI) in CPRD GOLD. Patients undergoing hip or knee arthroplasty in both databases exhibited different sociodemographic characteristics and medical/drug history. However, the quantification of the impact of such covariates (coefficients of parametric models fitted to the survival curves) on the risk of PJI between the two cohorts was not statistically significant. The log-normal model fitted to the pooled cohorts after stepwise selection had a C-statistic >0.7.
Conclusions
The risk prediction tool developed here could help prevent PJI through identifying modifiable risk factors pre-surgery and identifying the patients most likely to benefit from close monitoring/preventive actions. As derived from the UK population, such tool will help the National Health Service reduce the impact of PJI on its resources and patient lives.